Silverfin false false 30/11/2023 01/12/2022 30/11/2023 Sophie Dick 01/11/2021 James Wace 01/11/2021 06 August 2024 The principal activity of the company during the year was business and domestic software development. 13714418 2023-11-30 13714418 bus:Director1 2023-11-30 13714418 bus:Director2 2023-11-30 13714418 2022-11-30 13714418 core:CurrentFinancialInstruments 2023-11-30 13714418 core:CurrentFinancialInstruments 2022-11-30 13714418 core:ShareCapital 2023-11-30 13714418 core:ShareCapital 2022-11-30 13714418 core:SharePremium 2023-11-30 13714418 core:SharePremium 2022-11-30 13714418 core:CapitalRedemptionReserve 2023-11-30 13714418 core:CapitalRedemptionReserve 2022-11-30 13714418 core:RetainedEarningsAccumulatedLosses 2023-11-30 13714418 core:RetainedEarningsAccumulatedLosses 2022-11-30 13714418 bus:OrdinaryShareClass1 2023-11-30 13714418 bus:OrdinaryShareClass2 2023-11-30 13714418 bus:OrdinaryShareClass3 2023-11-30 13714418 2022-12-01 2023-11-30 13714418 bus:FilletedAccounts 2022-12-01 2023-11-30 13714418 bus:SmallEntities 2022-12-01 2023-11-30 13714418 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 13714418 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 13714418 bus:Director1 2022-12-01 2023-11-30 13714418 bus:Director2 2022-12-01 2023-11-30 13714418 1 2022-12-01 2023-11-30 13714418 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2022-12-01 2023-11-30 13714418 2021-11-01 2022-11-30 13714418 bus:OrdinaryShareClass1 2022-12-01 2023-11-30 13714418 bus:OrdinaryShareClass1 2021-11-01 2022-11-30 13714418 bus:OrdinaryShareClass2 2022-12-01 2023-11-30 13714418 bus:OrdinaryShareClass2 2021-11-01 2022-11-30 13714418 bus:OrdinaryShareClass3 2022-12-01 2023-11-30 13714418 bus:OrdinaryShareClass3 2021-11-01 2022-11-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 13714418 (England and Wales)

TALAMO LIMITED
(Formerly Talamo Dyslexia Diagnosis Limited)

Unaudited Financial Statements
For the financial year ended 30 November 2023
Pages for filing with the registrar

TALAMO LIMITED

Unaudited Financial Statements

For the financial year ended 30 November 2023

Contents

TALAMO LIMITED

STATEMENT OF FINANCIAL POSITION

As at 30 November 2023
TALAMO LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 30 November 2023
30.11.2023 30.11.2022
£ £
Fixed assets
Intangible assets 186,733 0
186,733 0
Current assets
Debtors 3 64,174 19
Cash at bank and in hand 78,482 97,824
142,656 97,843
Creditors: amounts falling due within one year 4 ( 27,052) ( 14,832)
Net current assets 115,604 83,011
Total assets less current liabilities 302,337 83,011
Net assets 302,337 83,011
Capital and reserves
Called-up share capital 5 200 182
Share premium account 359,962 99,989
Capital redemption reserve 9 0
Profit and loss account ( 57,834 ) ( 17,160 )
Total shareholders' funds 302,337 83,011

For the financial year ending 30 November 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Talamo Limited (registered number: 13714418) were approved and authorised for issue by the Board of Directors on 06 August 2024. They were signed on its behalf by:

James Wace
Director
TALAMO LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 November 2023
TALAMO LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 November 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.

General information and basis of accounting

Talamo Dyslexia Diagnosis Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 3 Buckland House, William Prance Road, Plymouth, PL6 5WR, United Kingdom. The business address of the Company is 1010 Fladgate House, 4 Circus Road West, Battersea Power Station, London, SW11 8EX.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Development costs are not amortised until the project is complete and brought into use. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Development costs not amortised
Research and development

Research expenditure is written off as incurred. Development expenditure is also written off, except where the directors are satisfied as to the technical, commercial and financial viability of individual projects. In such cases, the identifiable expenditure is capitalised as an intangible asset and amortised over the period during which the Company is expected to benefit. This period is between three and five years. Provision is made for any impairment. Amortisation is not applied until the project is complete and brought into use.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

2. Employees

Year ended
30.11.2023
Period from
01.11.2021 to
30.11.2022
Number Number
Monthly average number of persons employed by the Company during the year, including directors 3 2

3. Debtors

30.11.2023 30.11.2022
£ £
VAT recoverable 18,130 0
Corporation tax 46,004 0
Other debtors 40 19
64,174 19

4. Creditors: amounts falling due within one year

30.11.2023 30.11.2022
£ £
Trade creditors 1,291 0
Amounts owed to directors 10,965 11,832
Accruals 3,000 3,000
Other taxation and social security 11,087 0
Other creditors 709 0
27,052 14,832

5. Called-up share capital

30.11.2023 30.11.2022
£ £
Allotted, called-up and fully-paid
18,970 Ordinary A shares of £ 0.01 each (30.11.2022: 16,280 shares of £ 0.01 each) 189.70 162.80
1 Ordinary B share of £ 0.01 (30.11.2022: 855 shares of £ 0.01 each) 0.01 8.55
1,025 Ordinary C shares of £ 0.01 each 10.25 10.25
199.96 181.60

During the year the company had the following share transactions:

- On 9 January 2023 the company repurchased 855 ordinary B shares of £0.01p each at par.
- On 25 January 2023 1 ordinary A share of 0.01p was reclassified as a B ordinary share of £0.01p.
- On 24 February 2023 1,605 ordinary A shares of 0.01p each were issued at a price of £93.457943 per share.
- On 7 June 2023 the company issued 1,086 A ordinary shares of £0.01p each at a price of £101.28913 per share.

6. Related party transactions

Transactions with the entity's directors

30.11.2023 30.11.2022
£ £
Amounts owed to directors as at 30 November 10,965 11,832